Emerging concepts in exercise training in chronic heart failure
Emerging concepts in exercise training in chronic heart failure
Microvascular damage during myocardial ischemia-reperfusion: pathophysiology, clinical implications and potential therapeutic approach evaluated by myocardial contrast echocardiography
Microvascular damage during myocardial ischemia-reperfusion: pathophysiology, clinical implications and potential therapeutic approach evaluated by myocardial contrast echocardiography
Role of growth hormone in chronic heart failure: therapeutic implications
Role of growth hormone in chronic heart failure: therapeutic implications
Original articles Endovascular treatment of carotid atherosclerotic disease: early and late outcome in a non-selected population
Original articles Endovascular treatment of carotid atherosclerotic disease: early and late outcome in a non-selected population
Angiographic follow-up after coronary implantation of the MultilinkTM stent: a prospective observation
Angiographic follow-up after coronary implantation of the MultilinkTM stent: a prospective observation
Original articles Coronary stenting beyond standard indications. Immediate and follow-up results
Original articles Coronary stenting beyond standard indications. Immediate and follow-up results
Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge?
Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge?
Left ventricular performance in chronic mitral regurgitation: temporal response to valve repair and prognostic value of early postoperative echocardiographic parameters
Left ventricular performance in chronic mitral regurgitation: temporal response to valve repair and prognostic value of early postoperative echocardiographic parameters
Twenty-five-year cardiovascular disease incidence among middle-aged men. Disease burden, time shape, predictors, risk probabilities
Twenty-five-year cardiovascular disease incidence among middle-aged men. Disease burden, time shape, predictors, risk probabilities
Editorial comment To stop or not to stop a clinical trial: that is the problem
Editorial comment To stop or not to stop a clinical trial: that is the problem